tiprankstipranks
Regenxbio 4.57M share Spot Secondary priced at $23.00
PremiumThe FlyRegenxbio 4.57M share Spot Secondary priced at $23.00
1M ago
Regenxbio announces $125M common stock offering
PremiumThe Fly
Regenxbio announces $125M common stock offering
1M ago
Nvidia initiated, Target upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nvidia initiated, Target upgraded: Wall Street’s top analyst calls
1M ago
REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
PremiumPress ReleasesREGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
2M ago
Regenxbio expects cash to fund operations into 2H25
PremiumThe Fly
Regenxbio expects cash to fund operations into 2H25
2M ago
Regenxbio reports Q4 EPS ($1.34), consensus ($1.27)
PremiumThe Fly
Regenxbio reports Q4 EPS ($1.34), consensus ($1.27)
2M ago
Regenxbio says CAMPSIITE trial of RGX-121 achieves primary endpoint
PremiumThe FlyRegenxbio says CAMPSIITE trial of RGX-121 achieves primary endpoint
2M ago
Regenxbio provides update from Phase I/II AFFINITY DUCHENNE trial of RGX-202
PremiumThe Fly
Regenxbio provides update from Phase I/II AFFINITY DUCHENNE trial of RGX-202
2M ago
Regenxbio reports ‘positive’ interim data from AAVIATE trial
PremiumThe Fly
Regenxbio reports ‘positive’ interim data from AAVIATE trial
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100